| Metric | Nov 7, 2024 FY24 Q3 | Feb 10, 2025 FY24 Q4 | May 8, 2025 FY25 Q1 | Aug 2, 2025 FY25 Q2 | Nov 6, 2025 FY25 Q3 | Jan 24, 2026 FY25 Q4 | May 7, 2026 FY26 Q1 | Aug 6, 2026 FY26 Q2 |
|---|---|---|---|---|---|---|---|---|
| For FY2026 | ||||||||
| Revenue | — | — | — | — | — | — | — | New“at least $650 million” |
| Revenue | — | — | — | — | — | — | New“at least $750 million” | — |
| Adjusted EBITDA | — | — | — | — | — | — | — | New“approximately $160 million” |
| Adjusted EBITDA | — | — | — | — | — | — | New“approximately $260 million” | — |
| For FY2025 | ||||||||
| Revenue | — | — | — | — | New“at least $840 million” | Reiterated“of at least $840 million” | — | — |
| Revenue | — | — | — | New“at least $717 million” | — | — | — | — |
| Revenue | — | — | New“at least $682 million” | — | — | — | — | — |
| Revenue | — | New“at least $575 million” | — | — | — | — | — | — |
| Adjusted EBITDA | — | — | — | — | New“approximately $375 million” | Reiterated“of approximately $375 million” | — | — |
| Adjusted EBITDA | — | — | — | New“approximately $277 million” | — | — | — | — |
| Adjusted EBITDA | — | — | New“approximately $259 million” | — | — | — | — | — |
| Adjusted EBITDA | — | New“approximately $145 million” | — | — | — | — | — | — |
| For FY2024 | ||||||||
| Revenue | New“at least $756 million” | — | — | — | — | — | — | — |
| Adjusted EBITDA | New“approximately $363 million” | — | — | — | — | — | — | — |
| No period stated | ||||||||
| Additional share repurchase authorization | — | — | — | — | New“$500 million” | — | — | — |
| Additional share repurchase authorization approved by board of directors | — | New“$564 million” | — | — | — | — | — | — |
| Share repurchase authorization, bringing the total amount of authorized future repurchases | — | New“$1 billion” | — | — | — | — | — | — |